Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | NOS2 | P35228 | 1/20 | 0.38 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1881445 | 0.77 | NOS3 (0.38) | NOS3NOS2LOXL2 | |
| SCHEMBL1886344 | 0.77 | NOS3 (0.38) | NOS3NOS2LOXL2 | |
| SCHEMBL791272 | 0.76 | NOS3 (0.36) | NOS3NOS2 | |
| SCHEMBL790082 | 0.76 | NOS3 (0.36) | NOS3NOS2 | |
| SCHEMBL8307241 | 0.76 | NOS3 (0.36) | NOS3NOS2 | |
| SCHEMBL8304809 | 0.76 | NOS3 (0.36) | NOS3NOS2 | |
| SCHEMBL5252803 | 0.72 | NOS3 (0.34) | NOS3NOS2 | |
| SCHEMBL1707520 | 0.71 | NOS3 (0.33) | NOS3NOS2 | |
| SCHEMBL22653643 | 0.71 | NOS3 (0.33) | NOS3NOS2 | |
| SCHEMBL1706799 | 0.71 | NOS3 (0.33) | NOS3NOS2LOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041854-A1 | COLD MEDICINE AND ANTIVIRAL MEDICINE | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2024-02-08 | — | — | US | disclosed |
| EP-4190329-A1 | COLD REMEDY AND ANTIVIRAL AGENT | Otsuka Pharmaceutical Factory, Inc. (JP) | 2023-06-07 | — | — | EP | disclosed |
| CN-102428082-A | Pyrimidine compounds and their use in pest control | SUMITOMO CHEMICAL CO | 2012-04-25 | — | — | CN | disclosed |
| US-20120041009-A1 | PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-16 | — | — | US | disclosed |
| WO-2010134478-A1 | PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-25 | — | — | WO | disclosed |
| EP-1417202-A2 | AMINOPIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | F. HOFFMANN-LA ROCHE AG (CH) | 2004-05-12 | — | — | EP | disclosed |
| US-20030069276-A1 | Amino piperidine derivatives | F.HOFFMANN-LA ROCHE AG (CH) | 2003-04-10 | — | — | US | disclosed |
| WO-2002079186-A2 | AMINOPIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | F. HOFFMANN-LA ROCHE AG (CH) | 2002-10-10 | — | — | WO | disclosed |
| EP-0576251-B1 | Substituted 1,2,4-triazine-3,5-dione derivatives and drug compositions containing them, particularly for coccidiosis treatment | SUNTORY LTD (JP) | 1999-11-24 | — | — | EP | disclosed |
| US-5424310-A | Substituted 1,2,4-triazine-3,5-dione derivative and anticoccidial drug composition containing the same as active component | SUNTORY LIMITED (JP) | 1995-06-13 | — | — | US | disclosed |
| EP-0576251-A1 | Substituted 1,2,4-triazine-3,5-dione derivatives and drug compositions containing them, particularly for coccidiosis treatment | SUNTORY LIMITED (JP) | 1993-12-29 | — | — | EP | disclosed |
| EP-0277915-B1 | PHOTOINITIATOR MIXTURE CONTAINING A TITANOCENE AND A 3-KETOCOUMARIN | CIBA-GEIGY AG (CH) | 1991-09-04 | — | — | EP | disclosed |
| US-5011755-A | Relief Images | CIBA-GEIGY CORPORATION (US) | 1991-04-30 | — | — | US | disclosed |
| EP-0277915-A2 | Photoinitiator mixture containing a titanocene and a 3-ketocoumarin | CIBA-GEIGY AG (CH) | 1988-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041854-A1 | COLD MEDICINE AND ANTIVIRAL MEDICINE | IRF3, MAVS, EIF2AK2 | NOS3 1459/4885NOS2 1534/4885LOXL2 4482/4885 |
| US-20030069276-A1 | Amino piperidine derivatives | CCR5, CCR2, CXCR4 | NOS3 1902/4885NOS2 1152/4885LOXL2 4527/4885 |
| US-20120041009-A1 | PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL | TYMP, DPYD, TYMS | NOS3 3485/4885NOS2 1933/4885LOXL2 1911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.